Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APDN |
---|---|---|
09:32 ET | 123 | 2.74 |
09:52 ET | 500 | 2.74 |
09:54 ET | 3900 | 2.66 |
10:14 ET | 150 | 2.685 |
10:15 ET | 100 | 2.71 |
10:26 ET | 370 | 2.6862 |
10:35 ET | 100 | 2.71 |
10:37 ET | 100 | 2.68 |
10:46 ET | 190 | 2.68 |
10:50 ET | 419 | 2.695 |
10:51 ET | 200 | 2.68 |
10:55 ET | 13472 | 2.51 |
10:57 ET | 9066 | 2.5001 |
11:00 ET | 100 | 2.51 |
11:04 ET | 2700 | 2.5999 |
11:15 ET | 1400 | 2.59 |
11:29 ET | 100 | 2.6163 |
11:33 ET | 200 | 2.62 |
11:38 ET | 825 | 2.6202 |
11:40 ET | 100 | 2.58 |
12:20 ET | 100 | 2.6 |
12:25 ET | 400 | 2.6001 |
12:36 ET | 900 | 2.62 |
12:43 ET | 500 | 2.595 |
12:48 ET | 500 | 2.595 |
01:03 ET | 1122 | 2.585 |
01:06 ET | 200 | 2.59 |
01:12 ET | 800 | 2.6198 |
01:17 ET | 100 | 2.58 |
01:21 ET | 100 | 2.6 |
01:30 ET | 101 | 2.5786 |
01:35 ET | 200 | 2.6199 |
01:46 ET | 3150 | 2.62 |
01:55 ET | 144 | 2.64 |
02:04 ET | 100 | 2.6395 |
02:06 ET | 450 | 2.62 |
02:08 ET | 1750 | 2.64 |
02:11 ET | 100 | 2.6501 |
02:18 ET | 500 | 2.6599 |
02:29 ET | 144 | 2.66 |
02:47 ET | 3238 | 2.57 |
02:58 ET | 3119 | 2.57 |
03:03 ET | 200 | 2.5601 |
03:05 ET | 111 | 2.565 |
03:32 ET | 1033 | 2.55 |
03:43 ET | 1000 | 2.5447 |
03:45 ET | 1425 | 2.57 |
03:48 ET | 1025 | 2.5236 |
03:50 ET | 922 | 2.5101 |
03:57 ET | 149 | 2.5101 |
03:59 ET | 127 | 2.51 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied DNA Sciences Inc | 2.7M | -0.1x | --- |
Vivos Therapeutics Inc | 7.3M | -0.2x | --- |
Acutus Medical Inc | 1.3M | -0.1x | --- |
Fuse Medical Inc | 6.1M | 2.3x | +2.06% |
Encision Inc | 5.9M | -13.1x | --- |
Signature Eyewear Inc | 10.0 | 0.0x | -26.18% |
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7M |
---|---|
Revenue (TTM) | $5.5M |
Shares Outstanding | 984.7K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.18 |
EPS | $-17.13 |
Book Value | $7.25 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -261.64% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.